Schedule 13D ownership disclosure

Y-MABS THERAPEUTICS INC

Security class unavailable · CUSIP: 984241109

Event date: 2021-11-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,194,278
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-023330
Form type
SC 13D/A
Filer
Sofinnova Venture Partners X, L.P.
CIK
CIK 1680200
Filed
Feb 15, 2022
Reporting period
Nov 04, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub